Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial

202120 citationsJournal Articlebronze Open Access

Authors

Alexandra J. Lansky · Queen Mary University of London

Dean J. Kereiakes · Christ Hospital

Andreas Baumbach · Queen Mary University of London

Stephan Windecker · University Hospital of Bern

Yasin Hussain · Yale University

Cody Pietras · Yale University

Ovidiu Dressler ·

Abstract

Among patients with acute and chronic coronary syndromes undergoing percutaneous coronary intervention, the Supreme DES proved to be noninferior to the standard DP-EES. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03168776.

Topics & Keywords

Coronary Interventions and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 143, Issue 22, pp. 2143-2154

DOI: 10.1161/circulationaha.120.052482

Field-Weighted Citation Impact: 3.55